XHC:CA:TSX-iShares Global Healthcare (CAD Hedged) (CAD)

ETF | Sector Equity |

Last Closing

CAD 74.25

Change

+0.13 (+0.18)%

Market Cap

CAD 0.65B

Volume

1.50K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-04 )

Largest Industry Peers for Sector Equity

Symbol Name Price(Change) Market Cap
TEC:CA TD Global Technology Leaders I..

+0.51 (+1.28%)

CAD 2.91B
ZWU:CA BMO Covered Call Utilities ETF

-0.02 (-0.18%)

CAD 1.94B
XIT:CA iShares S&P/TSX Capped Informa..

+1.24 (+2.16%)

CAD 0.65B
TXF:CA First Asset Tech Giants Covere..

+0.26 (+1.21%)

CAD 0.65B
HTA:CA Harvest Tech Achievers Growth ..

+0.24 (+1.26%)

CAD 0.63B
ZUT:CA BMO Equal Weight Utilities Ind..

+0.06 (+0.27%)

CAD 0.45B
CWW:CA iShares Global Water Common Cl..

N/A

CAD 0.34B
XUT:CA iShares S&P/TSX Capped Utiliti..

+0.04 (+0.14%)

CAD 0.32B
COW:CA iShares Global Agriculture Com..

+0.64 (+1.02%)

CAD 0.28B
ZUH:CA BMO Equal Weight US Health Car..

+0.31 (+0.44%)

CAD 0.27B

ETFs Containing XHC:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Sector Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 11.34% 63% D 50% F
Dividend Return 0.56% 35% F 17% F
Total Return 11.90% 49% F 47% F
Trailing 12 Months  
Capital Gain 12.59% 31% F 38% F
Dividend Return 2.42% 61% D- 42% F
Total Return 15.00% 34% F 39% F
Trailing 5 Years  
Capital Gain 54.24% 54% F 71% C-
Dividend Return 6.91% 52% F 23% F
Total Return 61.15% 57% F 68% D+
Average Annual (5 Year Horizon)  
Capital Gain 7.63% N/A N/A 63% D
Dividend Return 8.69% N/A N/A 62% D
Total Return 1.05% N/A N/A 37% F
Risk Return Profile  
Volatility (Standard Deviation) 8.58% N/A N/A 85% B
Risk Adjusted Return 101.23% N/A N/A 97% N/A
Market Capitalization 0.65B 94% A 63% D

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.